OP-051 Baroreceptor Activation Therapy with Barostim Neo for Treatment of Resistant Hypertension and/or Heart Failure: First Reported 2 Cases in Turkey
Background Baroreceptor activation therapy (BAT) is a novel therapeutic option employed in treatment of resistant hypertension (HT) and/or heart failure (HF). Barostim neo is a minimally invasive device baroreceptor activation…